BCV
IBB icon

Banque Cantonale Vaudoise’s iShares Biotechnology ETF IBB Stock Holding History

Banque Cantonale Vaudoise’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$362 Hold
1,905
– – ﹤0.01% 569
2026
Q1 		$322K Sell
1,905
-110
-5% -$18.8K 0.01% 570
2025
Q4 		$340K Hold
2,015
– – 0.01% 497
2025
Q3 		$291K Sell
2,015
-5,382
-73% -$735K 0.01% 521
2025
Q2 		$936K Sell
7,397
-580
-7% -$71.2K 0.04% 364
2025
Q1 		$1.02M Buy
+7,977
New +$1.08M 0.04% 351
2024
Q3 		$1.22M Sell
8,397
-1,655
-16% -$239K 0.05% 287
2024
Q2 		$1.38M Sell
10,052
-9,742
-49% -$1.3M 0.05% 292
2024
Q1 		$2.72M Buy
19,794
+1,443
+8% +$197K 0.11% 200
2023
Q4 		$2.49M Sell
18,351
-1,454
-7% -$177K 0.11% 194
2023
Q3 		$2.42M Buy
19,805
+2,101
+12% +$267K 0.12% 137
2023
Q2 		$2.25M Buy
17,704
+6,631
+60% +$861K 0.1% 168
2023
Q1 		$1.43M Sell
11,073
-551
-5% -$72.1K 0.07% 252
2022
Q4 		$1.53M Sell
11,624
-420
-3% -$54.3K 0.08% 227
2022
Q3 		$1.41M Buy
12,044
+2,611
+28% +$324K 0.08% 248
2022
Q2 		$1.11M Sell
9,433
-189
-2% -$22.4K 0.06% 326
2022
Q1 		$1.25M Buy
9,622
+804
+9% +$105K 0.05% 335
2021
Q4 		$1.35M Buy
8,818
+2,768
+46% +$429K 0.05% 345
2021
Q3 		$979K Buy
6,050
+614
+11% +$103K 0.04% 412
2021
Q2 		$890K Buy
5,436
+226
+4% +$34.8K 0.04% 449
2021
Q1 		$784K Sell
5,210
-330
-6% -$52.4K 0.04% 432
2020
Q4 		$840K Sell
5,540
-500
-8% -$71.5K 0.05% 350
2020
Q3 		$818K Buy
6,040
+3,380
+127% +$459K 0.05% 310
2020
Q2 		$364K Sell
2,660
-180
-6% -$22.9K 0.03% 489
2020
Q1 		$306K Sell
2,840
-150
-5% -$17.3K 0.03% 513
2019
Q4 		$360K Buy
+2,990
New +$334K 0.02% 578

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Banque Cantonale Vaudoise's IBB Position: Q2 2026 in Review

Banque Cantonale Vaudoise held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 1,905 shares worth $362. The position accounts for ﹤0.01% of the portfolio, ranked #569.

Banque Cantonale Vaudoise first reported a position in IBB in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.72M in Q1 2024. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Banque Cantonale Vaudoise held 1,905 shares of iShares Biotechnology ETF worth $362 as of Q2 2026.
  • Banque Cantonale Vaudoise left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #569 holding.
  • Banque Cantonale Vaudoise first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 26 quarters since.
  • Banque Cantonale Vaudoise's iShares Biotechnology ETF position peaked at $2.72M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.